Danlei Zhou
Shanghai Medical College of Fudan University(CN)Fudan University(CN)
Publications by Year
Research Areas
Immune Cell Function and Interaction, Cancer Immunotherapy and Biomarkers, Chronic Lymphocytic Leukemia Research, T-cell and B-cell Immunology, Cancer, Hypoxia, and Metabolism
Most-Cited Works
- → Intracellular complement C5a/C5aR1 stabilizes β-catenin to promote colorectal tumorigenesis(2022)97 cited
- → C5aR1 is a master regulator in Colorectal Tumorigenesis via Immune modulation(2020)88 cited
- → FOXM1D potentiates PKM2‐mediated tumor glycolysis and angiogenesis(2020)75 cited
- → CD59 is a potential biomarker of esophageal squamous cell carcinoma radioresistance by affecting DNA repair(2018)44 cited
- → Nuclear complement C3b promotes paclitaxel resistance by assembling the SIN3A/HDAC1/2 complex in non-small cell lung cancer(2023)20 cited
- → FOXM1c promotes oesophageal cancer metastasis by transcriptionally regulating IRF1 expression(2018)20 cited
- → Midostaurin potentiates rituximab antitumor activity in Burkitt’s lymphoma by inducing apoptosis(2018)14 cited
- → CD59-Regulated Ras Compartmentalization Orchestrates Antitumor T-cell Immunity(2022)11 cited
- → Increased α-HB links colorectal cancer and diabetes by potentiating NF-κB signaling(2023)11 cited
- → FOXM1D Potentiates PKM2-Mediated Tumor Glycolysis and Angiogenesis(2020)7 cited